Form 4: cbdMD Director Sells Over 550K Shares

cbdMD Director and 10% Owner Clark R. Crosnoe reported the sale of 550,701 shares of common stock across multiple transactions on December 17, 2025.

Summary

• Clark R. Crosnoe, a Director and 10% Owner of cbdMD, Inc. (YCBD), reported the sale of 550,701 shares of common stock.
• The transactions occurred on December 17, 2025, and were executed under a Rule 10b5-1 trading plan.
• A direct sale of 461,725 shares was made at a price of $2.3136 per share.
• Indirect sales included 69,875 shares at $2.3444 by CRC Investment Fund LP and 19,101 shares at $2.3444 by NM 2018 Trust.
• Following these transactions, Mr. Crosnoe's indirect beneficial ownership includes 361,400 shares via CRC Investment Fund LP, 56,875 shares via NM 2018 Trust, and 17,875 shares via AMC Legacy Trust.
• Mr. Crosnoe disclaims beneficial ownership of these securities except to the extent of his pecuniary interest.

Sentiment

Score: 3

Explanation: The significant sale of shares by a Director and 10% Owner, even under a 10b5-1 plan, generally indicates a negative sentiment regarding the company's near-term prospects or valuation. While the 10b5-1 plan suggests pre-planning rather than an immediate reaction to new information, the sheer volume of shares sold is a notable negative signal for investors.

Negatives

• A significant sale of 550,701 shares by a Director and 10% Owner, Clark R. Crosnoe, could be interpreted as a lack of confidence in the company's near-term prospects.
• The total value of shares sold exceeds $1.2 million (calculated as 461,725 * $2.3136 + 69,875 * $2.3444 + 19,101 * $2.3444).

Risks

• Insider selling can signal potential future underperformance or a belief that the stock is fully valued or overvalued.
• Reduced insider ownership might decrease alignment of interests between management and shareholders.

Future Outlook

NA

Industry Context

This Form 4 filing reports an insider transaction and does not provide specific industry context beyond the company's ticker (YCBD), which is associated with the CBD and wellness industry. Insider sales can sometimes be viewed in the context of broader industry trends, but this filing itself offers no direct commentary.

Related Party Transactions

• The indirect sales were conducted by CRC Investment Fund LP and NM 2018 Trust, entities through which Clark R. Crosnoe has beneficial ownership, indicating related party transactions in the context of insider reporting.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a negative signal, potentially leading to downward pressure on the stock price.
• Management/Employees: Could potentially impact morale if interpreted as a lack of confidence from a key insider, though the 10b5-1 plan mitigates this somewhat.

Key Dates

Recommendation

A significant insider sale by a Director and 10% owner, totaling over 550,000 shares, typically signals a lack of confidence in the company's future performance or a belief that the stock is currently overvalued. While the transaction was made pursuant to a Rule 10b5-1 plan, indicating it was pre-scheduled, the sheer volume of shares divested by a key insider suggests a cautious stance. Investors should consider this a negative indicator and potentially reduce exposure or avoid initiating new positions until clearer positive catalysts emerge.

Keywords

cbdMD, YCBD, Form 4, Insider Sale, Clark R. Crosnoe, Director, 10% Owner, Stock Transaction, SEC Filing, Rule 10b5-1